DIABETOMICS, INC. — TTAB Proceedings
DIABETOMICS, INC. is a party to 5 TTAB proceedings.
Proceedings
- Proceeding 91292503 — Oppositions, Terminated (filed 2024-07-08) against Abbott Laboratories as defendant
- Proceeding 97924951 — Extensions of Time to Oppose, Terminated (filed 2024-04-04) against Abbott Laboratories as defendant
- Proceeding 88508440 — Extensions of Time to Oppose, Terminated (filed 2019-12-09) against Abbott Laboratories as defendant
- Proceeding 87024827 — Extensions of Time to Oppose, Terminated (filed 2016-11-14) against Sanofi Biotechnology as defendant
- Proceeding 86884548 — Extensions of Time to Oppose, Terminated (filed 2016-06-08) against Roche Diabetes Care, Inc. as defendant
Marks in These TTAB Matters
Recent Live Filings
- COVAB — Registered, filed 2021-04-23
- INSUDEX — Registered, filed 2016-05-04
- LUMELLA — Registered, filed 2015-04-30
- DIABETOMICS — Registered, filed 2008-07-07
Common TTAB Counterparties
- Abbott Laboratories — 3 proceedings
- Roche Diabetes Care, Inc. — 1 proceedings
- Sanofi Biotechnology — 1 proceedings
Recent TTAB Timeline
- 2025-06-18: 91292503 — TERMINATED involving Abbott Laboratories
- 2025-06-18: 91292503 — BOARD'S DECISION: SUSTAINED involving Abbott Laboratories
- 2025-04-25: 91292503 — NOTICE OF DEFAULT involving Abbott Laboratories
- 2025-03-13: 91292503 — TRIAL DATES RESET involving Abbott Laboratories
- 2025-02-11: 91292503 — SUSP PEND DISP OF OUTSTNDNG MOT involving Abbott Laboratories
- 2025-02-07: 91292503 — P MOT TO AMEND PLEADING/AMENDED PLEADING involving Abbott Laboratories
- 2024-11-11: 91292503 — P APPEARANCE / POWER OF ATTORNEY involving Abbott Laboratories
- 2024-08-09: 91292503 — ANSWER involving Abbott Laboratories
- 2024-07-08: 91292503 — PENDING, INSTITUTED involving Abbott Laboratories
- 2024-07-08: 91292503 — NOTICE AND TRIAL DATES SENT; ANSWER DUE: involving Abbott Laboratories
- 2024-07-08: 91292503 — FILED AND FEE involving Abbott Laboratories
- 2024-04-04: 97924951 — EXTENSION OF TIME GRANTED involving Abbott Laboratories
- 2024-04-04: 97924951 — FIRST 90-DAY REQUEST TO EXT TIME TO OPPOSE involving Abbott Laboratories
- 2019-12-09: 88508440 — EXTENSION OF TIME GRANTED involving Abbott Laboratories
- 2019-12-09: 88508440 — FIRST 90-DAY REQUEST TO EXT TIME TO OPPOSE involving Abbott Laboratories
- 2016-11-14: 87024827 — EXTENSION OF TIME GRANTED involving Sanofi Biotechnology
- 2016-11-14: 87024827 — INCOMING - EXT TIME TO OPPOSE FILED involving Sanofi Biotechnology
- 2016-06-09: 86884548 — EXTENSION OF TIME GRANTED involving Roche Diabetes Care, Inc.
- 2016-06-09: 86884548 — EXTENSION OF TIME GRANTED involving Roche Diabetes Care, Inc.
- 2016-06-08: 86884548 — INCOMING - EXT TIME TO OPPOSE FILED involving Roche Diabetes Care, Inc.
- 2016-06-08: 86884548 — INCOMING - EXT TIME TO OPPOSE FILED involving Roche Diabetes Care, Inc.
- 2016-06-08: 86884548 — EXTENSION OF TIME GRANTED involving Roche Diabetes Care, Inc.
- 2016-06-08: 86884548 — INCOMING - EXT TIME TO OPPOSE FILED involving Roche Diabetes Care, Inc.